Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Verubecestat shows promising results as a BACE1 inhibitor

April 9, 2015

Novel markers of poor prognoses in lung adenocarcinoma

April 9, 2015

Analysis of HLA genes links genotypes to risk of atherosclerosis in patients with psoriasis

April 8, 2015

GlaxoSmithKline's SARM for muscle wasting diseases

April 8, 2015

Targeting IRS proteins presented as a new approach for prostate cancer therapy

April 8, 2015

GlaxoSmithKline describes novel inhibitors of RIP-1 and RIP-2 kinases

April 8, 2015

sGC activators prevent progression of diabetic nephropathy

April 8, 2015

New OX2R antagonist shows potential for the treatment of insomnia

April 8, 2015

rHuCat-L shows promising results for the treatment of cellulite

April 8, 2015

Novel sensor shows potential for blood ammonia management

April 7, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...